We are aware of current issues with the ONS login. Please clear your device history/cache/cookies before attempting to log in. Thank you for your patience as we address this issue.
cancel
KRN5500
KRN 5500 is a spicamycin derivative that has appeared to reduce nerve-injury-induced neuropathic pain in animal models. This substance was examined for its effect on pain in patients with cancer who had refractory neuropathic pain.